Business pioneers in technology

The industry’s rapid cycles have been an opportunity for young outsiders to bring in a fresh perspective

Pharma dealmaking helps lift US stocks

Energy sector powers ahead in spite of slide in crude

City jobs lost in spite of upbeat outlook

Banks respond to pressure on profits and need to streamline operations

City accused of failing life sciences

Sector too dependent on GSK and AstraZeneca, says top scientist

Brics banker goes to war on superbugs

Jim O’Neill is leading the drive to tackle drug-resistant superbugs

Dr Google assists in robotic surgery

Collaboration with J&J on operating table systems

©Stevie Mann

Parasitology: Parasites as protectors

A new strategy could have an impact on malaria

Mycology: fungi that glow in the dark

Bioluminescence helps Brazilian mushroom attract insects

Zebra fish
©James E. Minchin

Genetics: fat is a fishy issue

How genetically modified fish provide insight on body fat storage in humans

Actavis lab

Actavis rewrites ‘big pharma’ playbook

Are big, lean dealmakers running out of targets?

Drugs groups unite to mine genetic data

Groups to join 100,000 Genomes Project

Moulton-backed RedX Pharma to list on Aim

UK life science industry shows sign of life beyond southeast

Phones v real world: a techie’s quandary

Balancing digital and natural is tricky, says Jessica Butcher

Apple climbs after $1tn valuation call

US equities trade near record territory

Cern project yields thoughtful designs

Research at Large Hadron Collider benefits from student touch

Silicon Valley lands on big pharma’s turf

Tech industry’s turn to healthcare unsettles drugmakers

Common weedkiller labelled as cancer risk

WHO says Roundup is ‘probable carcinogen’

Feathers fly over Bath’s ‘vermin on wings’

Gull wars in spa town reflect growing problem in UK as seabirds invade towns

Biogen’s Alzheimer’s drug shows early promise

Experimental treatment slows rate of cognitive decline

Archaeology: Stone Age leaves its mark on the Sahara

The Messak Settafet in Libya is the earliest known example of an entire landscape being modified by ancient humans

Synthetic biology: How to peel fruits’ chemicals

New method of producing nootkatone offers the best combination of affordability and sustainability

Could there be life under Jupiter and Saturn’s lunar oceans?

Three recent discoveries keep up the drumbeat of excitement about extraterrestrial biology

Europe sees first eclipse of solar power era

Continent plunged into partial darkness but no impact on electricity supplies

Arctic sea ice shrinks to record low

Recent weather patterns partly explain change in coverage

Musk tempers autonomous driving claims

Software update to Tesla’s Model S promises ‘auto-steering’

LG Chem tips bright future for OLED lighting

Japanese and S Korean groups bet on next-generation technology

Welsh more Stone Age than other Britons

Genetics match regional identities, say researchers

Fund to fight drug-resistant infections

Focus on low and middle-income countries

Energy ideas too crazy for US private cash

Arpa-E has rare bipartisan backing to use government funds

Malin aims to raise €300m with IPO

Company closes in on one of Europe’s biggest biotech flotations

Q&A: Why stable CO2 emissions are vital

Figures show emissions growth can slow as economic growth rises

Global carbon emissions stall in 2014

First non-recession halt to CO2 growth for 40 years

Google-backed group hires top scientist

Scheller hired for genetic testing company

Carmakers fight ‘demonisation’ of diesel

Manufacturers fear backlash that ignores technical advances

Iniesta backs Telefónica wearable tech

Telefónica has paid €60,000 for 7 per cent stake in FirstV1sion

A gadget between sorcery and science

Polygraphs continues to bewitch governments

NTT Data reveals Vatican treasures

Japanese company digitises manuscripts and drawings by the likes of Michelangelo and Galileo

The challenges of remote MBA study

What is it like to study from afar?

Going the extra mile to win a $21bn deal

How AbbVie came out on top in pharma’s most competitive auction

AbbVie deal adds to pharma scramble

Merger boom fuelled by need to boost pipelines